Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer

Husinka, L; Koerner, PH; Miller, RT; Trombatt, W

Husinka, L (corresponding author), 106 Bookbinder Cir, Pittsburgh, PA 15212 USA.

JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1): 27

Abstract

Objective The purpose of this study is to review CDK 4/6 inhibitors used to treat metastatic breast cancer for patient safety, cost and utilization. B......

Full Text Link